title: Further observations on serotype 2 Marek's disease virus-induced enhancement of spontaneous avian leukosis virus-like bursal lymphomas in ALVA6 transgenic chickens.
abstract: Breeders of the 2009 generation of Avian Disease and Oncology Laboratory transgenic chicken line ALVA6, known to be resistant to infection with subgroups A and E avian leukosis virus (ALV), were vaccinated at hatch with a trivalent Marek's disease (MD) vaccine containing serotypes 1, 2, and 3 Marek's disease virus (MDV) and were maintained under pathogen-free conditions from the day of hatch until 75 weeks of age. Spontaneous ALV-like bursal lymphomas, also termed lymphoid leukosis (LL)-like lymphomas, were detected in 7% of the ALVA6 breeders. There was no evidence of infection with exogenous and endogenous ALV as determined by virus isolation tests of plasma and tumour tissue homogenates. For the next three generations, serotype 2 MDV was eliminated from the trivalent MD vaccine used. Results show, for the first time, that removal of serotype 2 MDV from MD vaccines eliminated spontaneous LL-like lymphomas within 50 to 72 weeks of age for at least three consecutive generations. Two experiments were also conducted to determine the influence of in ovo vaccination with serotype 2 MD vaccines on enhancement of spontaneous LL-like lymphomas in ALVA6 chickens. Chickens from the 2012 generation were each inoculated in ovo or at hatch with 5000 plaque-forming units of serotype 2 MDV. Results indicate that by 50 weeks of age the incidence of spontaneous LL-like lymphomas in chickens inoculated in ovo with serotype 2 MDV was comparable with that in chickens inoculated with virus at hatch, suggesting that the augmentation effect of serotype 2 MDV is independent of age of vaccination.
authors.affiliation: a Avian Disease and Oncology Laboratory , USDA Agriculture Research Service , East Lansing , MI , USA.
authors.forename: Weisheng
authors.initials: W
authors.lastname: Cao
authors.forename: Jody
authors.initials: J
authors.lastname: Mays
authors.forename: Gururaj
authors.initials: G
authors.lastname: Kulkarni
authors.forename: John
authors.initials: J
authors.lastname: Dunn
authors.forename: Richard M
authors.initials: RM
authors.lastname: Fulton
authors.forename: Aly
authors.initials: A
authors.lastname: Fadly
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics*; D001354:Avian Leukosis Virus / Q000276:immunology; D002060:Bursa of Fabricius / Q000473:pathology* / Q000821:virology; D002645:Chickens; D025961:Herpesvirus 3, Gallid / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D008223:Lymphoma / Q000473:pathology / Q000662:veterinary* / Q000821:virology; D016133:Polymerase Chain Reaction; D011201:Poultry Diseases / Q000473:pathology* / Q000821:virology*; D013045:Species Specificity; D014765:Viral Vaccines / Q000235:genetics / Q000627:therapeutic use
chemical_list: D014765:Viral Vaccines